FEMY Logo

Femasys Inc. (FEMY) 

NASDAQ
Market Cap
$25.65M
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
676 of 971
Rank in Industry
36 of 50

Largest Insider Buys in Sector

FEMY Stock Price History Chart

FEMY Stock Performance

About Femasys Inc.

Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.

Insider Activity of Femasys Inc.

Over the last 12 months, insiders at Femasys Inc. have bought $0 and sold $0 worth of Femasys Inc. stock.

On average, over the past 5 years, insiders at Femasys Inc. have bought $2.6M and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 1,000 shares for transaction amount of $9,950 was made by Dyett John () on 2021‑06‑23.

List of Insider Buy and Sell Transactions, Femasys Inc.

2021-06-23Purchase
1,000
0.0459%
$9.95$9,950-61.10%
2021-06-22Purchasedirector
100,000
6.2919%
$13.00$1.3M-58.84%
2021-06-22Purchase
40,000
2.5168%
$13.00$520,000-58.84%
2021-06-22Purchasedirector
40,000
2.5168%
$13.00$520,000-58.84%
2021-06-22Purchasedirector
7,000
0.4404%
$13.00$91,000-58.84%
2021-06-18Purchase
12,500
0.6491%
$12.94$161,750-65.46%

Insider Historical Profitability

<0.0001%
Uzialko Edward Rdirector
127786
0.5581%
$1.1210<0.0001%
Dyett John
114709
0.5009%
$1.1230<0.0001%
Adams John Q JRdirector
40000
0.1747%
$1.1210<0.0001%
Larsen Charlesdirector
7000
0.0306%
$1.1210<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.